In order to determine whether dysregulated INHBA/ActA-mediated angiocrine affects the development of PAH, we generated mice in which INHBA was overexpressed under the control of the VE-cadherin promoter (VEcad-INHBA-Tg). This evidence concerns the gene CDH5 and pulmonary arterial hypertension.